An Update Regarding Using TMS for Smoking Cessation

An Update Regarding Using TMS for Smoking Cessation

You’re invited to join the Clinical TMS Society for this installment of our Grand Round Webinar Series: An Update Regarding Using TMS for Smoking Cessation

Presentation Overview: 

  1. Be familiar with the preclinical and clinical work over the past decade indicating the TMS might be helpful to treat smoking addiction. 
  2. Understand the basic design of a recent clinical trial that led to FDA approval of deep TMS for smoking cessation. 
  3. Be able to describe different issues involved in using TMS for smoking addiction in a clinical practice setting.

Date of Release: December 4, 2020

Date of Expiration: December 3, 2022


Cost: Members: $25 | Non-members $50 | Student Members FREE

SPEAKER: Mark George, MD

Dr. George first began studying the relationship between mind and brain, or brain/behavior relationships while he was an undergraduate philosophy student at Davidson College.  He then received his medical degree from the Medical University of South Carolina in Charleston in 1985, where he continued with dual residencies in both neurology and psychiatry. He is board certified in both areas. 
Following his residency training he completed serial research fellowships, first in England and then at the NIH. While he was at the Institute of Neurology, Queen Square, London, England (1989-90), he used the new tools of functional imaging (PET and SPECT) to investigate the brain regions involved in normal emotions and brain changes that occur in depression and mania. He was also lucky to be exposed to a brand new technology, transcranial magnetic stimulation (TMS).
He then moved to Washington, DC, working with Dr. Robert Post in the Biological Psychiatry Branch of the Intramural National Institute of Mental Health (NIMH).  During his 4 years at NIMH he continued with brain imaging (now fMRI) and began using TMS as a probe of neuronal circuits regulating mood, and in clinical trials using TMS as an antidepressant. In 1993 while at the NIMH, he discovered that daily prefrontal rTMS over several weeks could treat depression. He has since worked to grow the science of TMS and other forms of brain stimulation, both in terms of how they work in the brain, and in critically evaluating their therapeutic applications. 
He returned to MUSC in 1996 and created a research brain imaging center and the Brain Stimulation Division within the department of psychiatry, which he still directs. In June 1998 at MUSC, he also helped pioneer another new treatment for resistant depression, cervical vagus nerve stimulation (VNS). This was FDA approved in 2006. Most recently he was the PI on an international trial that resulted in TMS being FDA approved to help with smoking cessation.
Dr. George is thus a world expert in brain imaging and brain stimulation, particularly combining the two. He is the editor-in-chief of a new journal he launched with Elsevier in 2008 called, Brain Stimulation: Basic, Translation and Clinical Research in Neuromodulation. He has served as the chief editor for 13 years now and this journal is the top in its field. 
He has been continuously funded by NIH and other funding agencies since his fellowships. He has received both a NARSAD Young Investigator and Independent Investigator Award to pursue TMS research in depression. He has received numerous international awards including the NARSAD Klerman Award (2000), NARSAD Falcone Award (2008) and the Lifetime Achievement Award (2007) given by the World Federation of Societies of Biological Psychiatry (WFSBP). He is on several editorial review boards and NIH study sections, has published over 500 scientific articles or book chapters, and has written or edited 6 books. 
When he is not working he enjoys gardening, kite surfing, hiking and biking, and dreaming about the future of mankind and where neuroscience is headed...

Acknowledgement of Financial and/or In-Kind Commercial Support

No financial or in-kind commercial support was received for this educational activity.

Satisfactory Completion 

Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.   



In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation Statement – Amedco LLC designates this on-demand activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Questions? Email




December 1st, 2020 from  5:00 PM to  6:00 PM
Phone: 845-392-3238
Event Fee(s)
Fee Level
Webinar Registration | Non-Member $50.00